OpenEvidence
Cambridge, Massachusetts, United States · Artificial Intelligence, Health Care, Medical · 90 employees
OpenEvidence is a platform designed to assist doctors in making critical decisions at the point of care. It leverages advanced AI technology and is built specifically for medical professionals. The platform is free for verified doctors in the United States and is utilized by hundreds of thousands of healthcare providers. OpenEvidence is focused on expanding and organizing the world's collective me
Funding history
- Series series d — $250.0M — Jun 2026
- Series SERIES D — $250.0M — Jan 2026
- Funding Round — $200.0M — Oct 2025
Recent signals
- Jul 09, 2026: OpenEvidence and Anticoagulation Forum Form Partnership to Enhance AI-Enabled Antithrombotic Care.
- Jun 15, 2026: Raised $250.0M in Series series d
- Feb 26, 2026: Launched OpenEvidence launches the AI-Integrated Doctor Dialer™, a HIPAA-secure communications suite for telemedicine.
- Jan 21, 2026: Raised $250.0M in Series SERIES D
- Oct 20, 2025: Raised $200.0M
- Sep 10, 2025: Acquired OpenEvidence acquires Amaro to boost growth
See plans & pricing → Track OpenEvidence’s funding, hiring, and signals — with verified contacts — on Fundz.